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Mycoplasmas are fastidious microorganisms, typically characterised by their restricted metabolism 
and minimalist genome. Although there is reported evidence that some mycoplasmas can develop 
biofilms little is known about any differences in metabolism in these organisms between the growth 
states. A systematic metabolomics approach may help clarify differences associated between 
planktonic and biofilm associated mycoplasmas. In the current study, the metabolomics of two 
different mycoplasmas of clinical importance (Mycoplasma pneumoniae and Mycoplasma fermentans) 
were examined using a novel approach involving nuclear magnetic resonance spectroscopy and 
principle component analysis. Characterisation of metabolic changes was facilitated through the 
generation of high‑density metabolite data and diffusion‑ordered spectroscopy that provided the 
size and structural information of the molecules under examination. This enabled the discrimination 
between biofilms and planktonic states for the metabolomic profiles of both organisms. This work 
identified clear biofilm/planktonic differences in metabolite composition for both clinical mycoplasmas 
and the outcomes serve to establish a baseline understanding of the changes in metabolism observed 
in these pathogens in their different growth states. This may offer insight into how these organisms 
are capable of exploiting and persisting in different niches and so facilitate their survival in the clinical 
setting.
Mycoplasmas are facultatively anaerobic mollicutes that require an enriched growth media supplemented with 
nucleic acid precursors, fatty acids as well as amino acids to sustain their culture in laboratory conditions. These 
organisms are therefore considered to have a minimal  genome1. Mycoplasmas are typically divided into fermenta-
tive and non-fermentative groups according to their ability to produce acid from glucose and degrade arginine 
 respectively2,3. When grown under anaerobic conditions, lactate is the end product of the glucose oxidation, 
whereas under aerobic conditions, partial oxidation occurs and acetate and carbon dioxide  (CO2) are  formed4. 
Glucose and arginine are the substrates that are utilised as energy sources for mycoplasmas; thus, the majority of 
strains may be characterised according to whether they produce acid from glucose metabolism, ammonia from 
arginine hydrolysis or carry out both or neither of these  reactions5. Amino acids, fatty acids, metabolic precursors 
and even cholesterol are essential growth factors and play a vital role in mycoplasma  survival6. Due to the inability 
of mycoplasmas to synthesise macromolecules, they are dependent upon the nutrients found in host cells during 
 infection5,7. Mycoplasma survival can be enhanced by biofilm  formation8,9 and as a result, biofilms tend to be 
resistant to environmental conditions and host immune responses, relative to their planktonic  counterparts8–10.
The view proposed  by11,12 suggested that bacteria (potentially including mycoplasmas) attached to surfaces 
have differing metabolic activities compared to their planktonic counterparts due to physiochemical conditions 
and physiological characteristics expressed as a result of their growth. This phenomenon has been shown in 
biofilms produced by Vibrio parahaemolyticus, where a variety of cellular process including energy metabolism 
and biofilm development are influenced by certain  polysaccharides13. In order to better understand mycoplasma 
biofilms and their influence in disease a comprehensive characterisation of their differing metabolic states is 
necessary within this complex cellular community. Metabolomics can provide such a systematic approach 
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helping to clarify the complex mechanistics of biofilm states when compared with their free-living planktonic 
 counterparts14,15.
In the current study, NMR spectroscopy in conjunction with principle component analysis (PCA) was used 
to examine the mycoplasma metabolome (both planktonic and biofilm) and characterise metabolic changes in 
mycoplasma species. However, as the cellular metabolome normally incorporates thousands of metabolites it 
was not possible to exhaustively analyse every individual component. In order to manage the analysis of these 
metabolites, chemomx software was utilised to identify the major features within NMR spectrum, such as the 
absence or presence of peaks, the change in the shape of peak intensity, or the change in chemical shifts that 
distinguish between the two  classes16,17.
One-dimensional proton NMR (1D 1H NMR) is commonly used for global analysis of a  metabolome18–23. 
These experiments were able to identify the network of resonances associated with specific metabolites through 
J-coupling in a model  system24,25. The current study also used diffusion ordered spectroscopy (DOSY) NMR 
methodology to study the metabolome of planktonic and biofilm states for human mycoplasma preparations, 
providing size and structural information about the molecules  therein26. In DOSY- NMR, the diffusion motions 
of the components in samples are encoded and decoded using the application of a set of pulsed field gradients 
(PFG)27–31. A particularly novel application of DOSY NMR is the capacity for spectral binning and principal 
component analysis (PCA) of the diffusion coefficients for different regions. This is the first time this technique 
has been employed in mycoplasmal metabolome characterisation and significant metabolic changes between 
biofilm and planktonic mycoplasmas have been determined.
Materials and methods
Mycoplasma strains used in the study. A selection of clinical strains from the Kingston University cul-
ture collection were utilised in this study including eight clinical strains of Mycoplasma pneumoniae all isolated 
from human sputum samples and eight Mycoplasma fermentans strains isolated from a Kaposi’s sarcoma patient, 
joint fluid (2 isolates), respiratory tract (2 isolates), urine, urethra and a cell line isolate. All strains were stored as 
freeze-dried cultures and were grown and sub-cultured in fresh Eaton’s broth medium.
Growth of planktonic cells samples in liquid broth medium for M. pneumoniae and M. fermen-
tans strains. Isolates of both M. fermentans and M. pneumoniae were inoculated into Eaton’s broth medium 
(at a cell density of  106 cfu/ml) and incubated at 37 °C for 3–7 days to grow planktonic cells, whilst M. pneumo-
niae strains were incubated at 37 °C for approximately 30 days.
Growth of biofilm samples in liquid broth medium for M. pneumoniae and M. fermentans 
strains. Aliquots (2 ml) of M. fermentans and M. pneumoniae (at a cell density of  106 cfu/ml) were inoculated 
into 10 ml tissue culture flasks (Nunc, Fisher Scientific, UK) containing Eaton’s broth medium, and then incu-
bated as previously described. Following incubation, biofilms were acquired from the flask using a cell scraper 
(Becton, Dickenson Company, BD, UK) and aliquoted into sterile bijous for processing.
General NMR experimental for analysis of mycoplasma biofilm and planktonic serum 
extracts. A Bruker Avance III 600 MHz NMR spectrometer with 5 mm TXI Probe and temperature control 
unit was used for all 1D 1H NMR experiments. 5 mm Bruker Single Use NMR tubes (serum and DOSY). All 
spectra were acquired on Topspin 3.1 (Bruker, Germany). All NMR experiments were carried out at 25 °C. The 
Pulsecal routine was run prior to all experiments and the pulse angles adjusted accordingly for total correlated 
spectroscopy (TOCSY) and diffusion ordered spectroscopy (DOSY) experiments.
1H spectra for serum samples were acquired using 65,536 complex data points over a sweep width of 
20.57 ppm using a pre-saturation of the water signal at 4.7 ppm and one spoil gradient, Relaxation delay (d1) 
was set to 10 s with the RGA set to 256 for quantitation (See Supplementary Information S1 for example). Serum 
samples had pH of 7.4 and a 700 μl aliquot was diluted with 300 μl  D2O.
Diffusion spectra were obtained over 64 K data points (SW 10.3112 ppm) using longitudinal eddy current 
delay bipolar pulsed field gradient with 2 spoil gradients and pre-saturation sequence (LEDBPGPPR2s). This 
was used to obtain the diffusion series with δ = 4.6 ms and  = 125 ms. The relaxation delay was set to 4 s and the 
diffusion ramp consisted of 64 linear gradient steps, from 2 to 95% gradient intensity, each consisting of 16 scans.
Diffusion data was processed using a sine bell shaped window function phase over all data points prior to 
Fourier transformation (16,384 points) using Topspin 3.0 (Bruker, Germany). Diffusion data was processed using 
DOSY Toolbox, created by Mathias Nilsson, Manchester University. Individual peaks were fitted exponentially 
after a 2nd order polynomial baseline correction was  employed31.
Errors in diffusion coefficient were calculated based on the Standard Deviation for each diffusion curve and 
are in line with the estimated error as reported for a similar mixture of ca 0.1 ×  10–10  m2  s−1 31. The Residual Sum 
of Squares for each of the diffusion curves is less than 5 ×  10–3 in all cases.
1D 1H NMR evaluation of Mycoplasma fermentans and Mycoplasma pneumoniae in the serum 
based spent culture media. All 1D datasets were processed using Chenomx (Chenomx NMR Suite, Che-
nomx, Alberta, Canada). As has recently been  reported29, internal reference standards such as trimethylsilyl 
propionate (TSP) can often complex with proteins in the analysis and it is highly questionable that reliable direct 
quantitation of individual metabolites is possible in such a mixture. The relative amounts of individual metabo-
lites were of greater interest in a qualitative sense.
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Metabolites used in the PCA were restricted to those for which a concentration was detected by Chenomx 
in all samples. All data points were normalised (area) using Unscrambler 10, using a constant weighting and 
cross validation.
DOSY NMR evaluation of Mycoplasma fermentans and Mycoplasma pneumoniae in the serum 
based spent culture media. NMR spectra of metabolite mixtures are by their very nature complex and it 
was hypothesised that further information about metabolite mobility could be obtained using Diffusion Ordered 
Spectroscopy (DOSY). In addition, 1D NMR data provides many overlapping signals and while the Chenomx 
software is good at resolving some of the well-known metabolites, there was also a desire to investigate the exist-
ence of certain unknown metabolites. Through the use of a range of known metabolites as internal mass/diffu-
sion standards it is possible to plot a LogMr vs LogD graph to calculate the approximate mass of an unknown 
and this has been used to good effect in complex mixtures of this  type30.
Trying to automatically calculate diffusion coefficients from a pseudo 2D plot is not easily achieved and 
neither Amix nor Dosytoolbox are capable of dealing with the raw data to provide this output. DOSY spectra 
for both mycoplasmas were obtained for biofilm and planktonic samples in serum.
Therefore, the following process was adopted;
1. All DOSY spectra were calibrated with respect to both chemical shift and also diffusion, using internal 
standards of acetate, glucose, alanine and tyrosine. The range of molecular mass (Mr) afforded by this range 
of metabolites would enable the identification of an unknown Mr with good linearity  (R2 > 0.95)
2. The individual spectra were binned (515 bins) with 0.02 ppm increments and all signal intensities for each 
bin for each of the 64 gradient incremented spectra.
3. The diffusion coefficients for each bin were calculated using an Excel curve-fitting algorithm.
4. The above three steps were carried out for each spectrum.
5. Using the 8 samples for each of the strains of mycoplasma we obtained a spreadsheet 8 column wide by 515 
rows long with the matrix showing the diffusion coefficients for each bin for each sample. As water suppres-
sion was used the area of suppression was discounted from the spreadsheet.
6. For each strain of mycoplasma, the spreadsheet from 5 was analysed using Multibase 2015 addon to Excel 
and any differences analysed using PCA.
Metabolite identification. Using Chenomx Profiler (Chenomx NMR Suite, Chenomx, Alberta, Canada) 
1D processed datasets were analysed and the components assigned with the aid of TOCSY where appropriate. 
The pH was verified for each of the samples prior to processing so no internal pH standards were used and the 
line width and shifts were calibrated to formate as per the standard procedure for Chenomx data processing. 
Where assignment was ambiguous DOSY NMR was used to approximate the relative molecular mass (Mr) for 
individual components as previously  shown30.
Ethics approval. This research raised no ethical concerns for consideration as no human or animal subjects 
included in the experimental work.
Results
1D 1H NMR evaluation of Mycoplasma fermentans grown in serum containing medium. From 
a statistical perspective, both biofilm and planktonic samples of M fermentans were considered in isolation. 
Following the same processing parameters described previously in the methodology section, PCA analysis was 
carried out (Fig. 1). These data indicate statistically significant discrimination between biofilm and planktonic 
Mycoplasma fermentans based on 1D 1H NMR analysis and multivariate treatment for the first time in complex 
serum containing growth media such as Eatons medium (Fig. 2).  
According to the loadings plot (Fig. 3) it was possible to select those metabolites, which overall explained 
more than 50% of the variation observed in the 1D 1H NMR data and where there was a > 10% difference in the 
mean intensity of the signal for a metabolite between biofilm and planktonic NMR spectra (Fig. 2). 
The loadings plot explained more than 50% of the variation observed in the 1D 1H NMR data and where 
there was a > 10% difference in the mean intensity of the signal for a metabolite between biofilm and planktonic 
NMR spectra.
The concentration values were obtained for a cluster plot for accuracy and the signals were correlated to 
the individual metabolites that are described in the Chemnomx process in metabolite identification section in 
methodology.
As with all data analysed by unsupervised multivariant methods, the robustness of the data is directly cor-
related to the number of samples analysed (Supplementary Information S2).
The current study has shown discriminative patterns of metabolites for planktonic and biofilm cells of eight 
given strains of M. pneumoniae and M. fermentans. However, further samples and replicates would be necessary 
to re-enforce the power of this technique; moreover, further work would be useful to substantiate the significance 
of these results as they stand.
1D 1H NMR evaluation of Mycoplasma pneumoniae in the serum based spent culture media of 
both biofilm and planktonic growth conditions. Both biofilm and planktonic samples of M. pneumo-
niae were considered in isolation. Following the same processing parameters that were described previously in 
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the methodology section, PCA analysis was carried out indicating a statistically significant difference between 
the serum composition of biofilm and planktonic arrangements of M. pneumoniae (Fig. 4).
Using the loadings plot (Fig. 5), it was possible to select specific metabolites, which explained more than 50% 
of the variation observed in the 1D 1H NMR data and where there was a > 10% difference in the mean intensity of 
the signal for a metabolite between biofilm and planktonic NMR spectra (Supporting Information S3). The media 
components used in this study (Eaton’s media) in the absence of any Mycoplasma species, were also identified 
by 1D 1H NMR in order to provide baseline recognition of known metabolites, Chenomx software was used to 
analyse and identify the different metabolite components (Fig. 6).
Diffusion NMR analysis of Mycoplasma pneumoniae. The data was processed using MS Excel with 
the “Multibase 2015” add on and no weighting was applied to the variables since there is no precedent in the 
literature to aid explanation of the data and future investigations may be required to consider all possible impli-
cations of differing diffusion coefficients. The PCA analysis for M. pneumoniae shows that some of the variation 
between datasets could be explained using diffusion coefficient data. The fact that 3 PCs are required to explain 
95% of variation implies a certain degree of complexity in the way the data can show differences between biofilm 
and planktonic mycoplasmas and further investigation as to how this correlates to metabolite amplification is 
beyond the scope of the current study and requires further work (Fig. 7).
The PCA was carried out in order to identify which components had the most discriminatory aptitude (Fig. 8). 
Whilst the majority of signals were irrelevant with regards to the data set, it was possible to identify regions of 
the spectra which were correlated with the biofilm samples and those which correlated to the planktonic (Sup-
porting information S4).
The large number of metabolites appear to diffuse in a substantially different fashion making it a challenge 
to identify any one core component which accounts for the observed variation. However, some general observa-
tions can be made for example, that components at around 1 ppm seem to diffuse faster for biofilm mycoplasmas 
when compared to planktonic mycoplasmas (Supporting Inofrmation S5). Further work would be required to 
automate the correlation of the signals with a specific component. The introduction of operator assignment error 
when the bin size is as small as it is could easily lead to incorrect assignment of a signal to a specific metabolite.
Diffusion NMR analysis of Mycoplasma fermentans. PCA analysis of the diffusion data for M. fer-
mentans initially showed little grouping in the scores plot and this was confirmed by the statistical output, which 
showed a negative value for  Q2 and poor statistical explanation of the data. The residual variation was too high 
for this model and therefore further interrogation would have yielded unreliable pattern data (Supplementary 
Information S6), meaning this approach is not worth pursuing without optimisation on simpler systems.
Discussion
Mycoplasmas are characterised by limited biosynthetic capabilities, largely due to their minimal  genome32,33. Loss 
of genes involved in biosynthesis of lipids, amino acids, vitamins and cofactors during their  evolution34,35 has 
resulted in a reliance on external nutrients from host cells in vivo or rich media in vitro8,34. Furthermore, Myco-
plasma species are often deficient in intermediary energy metabolism, resulting in a lifestyle strictly dependent 
on the natural  host36. Reliance upon host cells for biosynthetic precursors may lead to competition and therefore 











Figure 1.  PCA scores plot for Mycoplasma fermentans (8 biofilm red filled circle and 8 planktonic blue filled 
square samples) from 1D 1H NMR analysis of serum.
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Mycoplasmas are divided into fermentative and non-fermentative  organisms2 according to their ability to 
catabolise carbohydrates via the phosphoenolpyruvate phosphotransferase (PEP-PTS)  system37. Glucose, and 
other fermentable sugars, are a crucial energy source, especially for the fermentative mollicutes. Glucose may 
also act as a precursor for the synthesis of other saccharides that stimulate the growth rate of  mollicutes38–40.
Host cell attachment by mycoplasmas, as a biofilm or part thereof, and cytotoxic metabolite production may 
contribute towards significant host cell damage, commonly observed in infection with these pathogens. Biofilm 
formation also frequently results in increased resistance to antimicrobial agents and persistence of many organ-
isms including M. fermentans and M. pneumoniae41–43. Physiological characterisation of biofilms is therefore 
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Figure 2.  Black square planktonic and black filled square biofilm (a) Low concentration range 0–100 mM (b) 
High concentration range 0–500 mM. Summary of the identified metabolites in Mycoplasma fermentans serum 
contributing an observed variation in component signal intensity of > 10% p = 0.05. Metabolites were assigned 
using Chemnomx Profiler. Certain duplicate signals (owing to multiplicity of single components in 1D 1H 
NMR) have been removed and the signal intensities averaged).
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Although global metabolite analysis has been proven as a powerful tool for understanding bacte-
rial  physiology26,27 the work presented here is the first DOSY-NMR metabolomics-based study in human 
mycoplasmas.
NMR-based metabolomics is a relatively new technology in biological applications and correspondingly has 
seen limited exploration in the investigation of microbial  biofilms17. The purpose of the evaluation of biofilm and 
planktonic mycoplasmas using 1D 1H NMR was to establish the amplification of one or more metabolites/media 
components (markers) dependent on the mycoplasma being grown either as a biofilm or in planktonic state. 
The use of 1D NMR techniques for the analysis of serum and also cytosolic contents are well  established25,28,31 
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Figure 3.  PCA Loadings plot for Mycoplasma fermentans from 1D 1H NMR analysis of serum. REMSEC value 
for y variable = 0.244.
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Figure 4.  PCA Scores Plot for Mycoplasma pneumoniae (8 biofilm blue filled square and 8 planktonic red filled 
circle samples) from 1D 1H NMR analysis of serum.
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and analysis of Acinetobacter baumannii strains using 1D NMR, 2D TOCSY and PCA analysis demonstrate the 
usefulness of these types of investigations in potentially elucidating details of the different metabolic pathways. 
The aim of the current research was to use these techniques to identify differences in metabolite composition 
for M. pneumoniae and M. fermentans in both biofilm and planktonic forming conditions. In addition, we 
aimed to evaluate the potential of Diffusion Ordered Spectroscopy (DOSY) to assist in discriminating between 
planktonic and biofilm mycoplasmas and what significance these points of discrimination may have, either to 
assist in the classification of a mycoplasma as either biofilm or planktonic derived, or to provide more informa-
tion about the constituents of the biofluid and potentially the differences in metabolic pathways. Additionally, 
this approach could also help to understand the potential changes in mycoplasmal metabolism under different 
growth conditions. The current study examines the overall metabolism of the organisms in the stated growth 
condition (planktonic or biofilm) and not the rate of metabolism. The measurement of bacterial metabolism for 
communities in a biofilm cannot reliably be measured and currently the metabolomic differences between the 
growth states as a whole is reported rather than growth rate  measurements44–48.
In reference to carbohydrate metabolism. many mycoplamas lack hexokinase, therefore glucose is transported 
into cells and ’captured’ by the phosphoenolpyruvate: phospho-transferase (PEP:PTS) system for degradation to 
pyruvate in the Embden–Meyerhof–Parnas (EMP) glycolytic  pathway49–54. Oxidative phosphorylation deficient 
mycoplasmas can metabolise pyruvate via two alternate pathways to generate ATP: oxidation by pyruvate dehy-
drogenase to acetyl-CoA, followed by the action of phosphate transacetylase and acetate kinase to yield acetate 
and ATP. Alternatively, pyruvate is reduced to lactate by lactate dehyrdogenase with concomitant oxidation of 
NADH to NAD to facilitate continued ATP generation via the  EMP50,53. Energy metabolism in mycoplasmas is 
therefore principally dependent on fermentation via the EMP to lactate under anaerobic conditions or acetate 
and  CO2 under aerobic  conditions3,34.
In M. fermentans, acetate was found to be greater in the biofilm suggesting that there is a bias toward the 
pyruvate dehydrogenase route for pyruvate metabolism. For both mycoplasma strains, the data indicates biofilms 
potentially produce more energy than planktonic cells. Glucose-6-phosphate was more abundant in planktonic 
cultures of both M. fermentans and M. pneumoniae, compared to biofilm serum (Figs. 2 and 6). Elevated uptake 
and ’capture’ of glucose and metabolism to the end-products lactate and acetate is required in order to generate 
the ATP necessary for growth and cellular  functions32, and thus facilitate the formation of biofilm.
The current study has identified ethanol (Figs. 2 and 6), an end-product of fermentative metabolism, as a 
metabolite; however, acetaldehyde which is the metabolic intermediate in ethanol formation from pyruvate was 
not identified. Similarly, alcohol dehydrogenase, the enzyme required for metabolism of pyruvate to ethanol 
was not experimentally detected in Mycoplasma pneumoniae. This observation concurs with M. pneumoniae 
proteomics  data32; however, the current study measured ethanol secretion by mass spectrometry. The ethanol 
level was higher in biofilms than planktonic cells in M. pneumoniae, whereas in M. fermentans it was observed 
to be higher in planktonic cells. This suggests that the ability to synthesise ethanol has a greater importance in 
the growth of M. pneumoniae biofilms. From the analysis of large metabolic  networks55,56, evidence from genetic 
studies and experimental investigations of protein  abundance57 it is apparent that Mycoplasma pneumoniae 
lacks almost all anabolic pathways, including those for amino acid synthesis and  metabolism32. Consequently, 
M. pneumoniae is dependent on the import of large amounts of amino  acids32 and the requirement for enriched 
PC-1 (47%)























































Figure 5.  PCA Loadings plot for Mycoplasma pneumoniae from 1D 1H NMR analysis of serum. REMSEC value 
for y variable = 0.252.
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Figure 6.  Black square planktonic and black filled square biofilm. (a) Low concentration range 0–100 mM (b) 
High concentration range 0–500 mM. Summary of the identified metabolites in Mycoplasma pneumoniae serum 
contributing an observed variation in component signal intensity of > 10% p = 0.05. Metabolites were assigned 
using Chemnomx Profiler. Certain duplicate signals (owing to multiplicity of single components in 1D 1H 
NMR) have been removed and the signal intensities averaged).
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culture media supplemented with  these1. In the current study, levels of amino acid metabolites were identified 
in both biofilms and their planktonic counterparts. Global analysis of M. pneumoniae metabolism indicated 
proteins mapped to the metabolic pathways in KEGG data base, including proline metabolic pathway (http://
www.genom e.jp/kegg/pathw ay/map/map00 330.html). The results showed that the proline level (in the form of 
4-Hydroxy-L-Proline) in M. pneumoniae was greater in biofilm cell serum compared to its planktonic counterpart 
(Figs. 2 and 6). This finding would suggest that proline iminopeptidase (Pip) may release proline from peptide 
and the aspartate-ammonia ligase (AsnA) catalyses the interconversion of aspartate and  asparagine33, and thus 
may be crucial for mycoplasma survival.
In M. fermentans, “arginine and proline” amino acid metabolic pathway has been recognised using genomic 
 studies33. M. fermentans produces ATP from arginine metabolism via the arginine dihydrolase (ADH) pathway, 
similar to that found in M. hominis33,58. The ADH pathway catalyses the conversion of arginine to ornithine, 
ATP,  CO2 and ammonia. The current work showed that arginine levels in Mycoplasma fermentans were greater 
in planktonic cells than biofilms.
Alanine was more prominent in biofilm metabolism of M. fermentans compared to its planktonic growth 
state (Figs. 2 and 6). This amino acid could be crucial in the absence of pyridoxal pyrophospahte as it could be 
a preferred element in the supplemented media instead of tyrosine and phenylalanine for optimum growth, 
suggesting the presence of an operative shikimic acid pathway for aromatic amino acids  synthesis40. Addition-
ally, alanine was observed to be marginally greater in the biofilm of M. pneumoniae (Figs. 2 and 6), which may 
Figure 7.  PCA scores plot analysis of the diffusion coefficients for 490 bins for Mycoplasma pneumoniae. 95% 
of the variation is explained by 3 PCs. With  R2 = 0.60 and  Q2 = 0.75 as the cumulative result of the 3 PCs.
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suggest that alanine was enriched in the cytosol due to the subsequent of cellular import from the surrounded 
growth  medium32.
Additionally, metabolite profiles in the current study demonstrated the presence of glycine and betaine, which 
are found to be higher in biofilms when compared with planktonic cells of sera for M. fermentans (Figs. 2 and 
6). Glycine is considered as a very efficient osmolyte found in a wide range of bacteria, where it is accumulated 
at high cytoplasmic  concentration58,59 in order to build up an internal osmotic strength and prevent the diffu-
sion of water out of the cells and thus maintain the cellular water  content59,60. When bacteria are grown at an 
inhibitory osmolarity, the enzyme activities that lead to glycine and betaine degradation decrease, whereas the 
enzyme activities that convert choline to glycine betaine either remain constant or  increase61. In this way, a high 
concentration of glycine betaine can be maintained in osmotically stressed  cells62. Mycoplasmas in nature are 
normally exposed to different types of stresses including osmolarity shifts and their resistance to different stresses 
is  noticed63,64. Consequently, the high level of these osmolytes in biofilm cells may indicate to their importance 
in growth and biofilm formation.
The metabolite profiles in the current study showed some interesting observations, such as the presence of 
valine and alloisoleucine in M. pneumoniae (Supplementary information S4 for M. pneumoniae). Depending 
on the examination of the phylogenetic distribution of the enzymes participating in isoleucine/valine metabolic 
pathway, it was found that all the genes coding for the enzymes of isoleucine/valine biosynthesis were missing in 
M. pneumoniae65. Thus, the presence of these metabolites in the profile might be related to the high nutritional 
value and complexity of the surrounding growth medium. This study also identified the presence of creatine in 
the biofilm of both M. fermentans and M. pneumoniae were higher than their planktonic counterparts (Figs. 2 
and 6). The presence of creatine is correlated to the biosynthetic pathway of arginine that involves the conversion 
of citrulline to arginine catalysed by arginosucciante synthase, which in turn provides the essential arginine for 
creatine biosynthesis. Creatine, the end product of the pathway, acts to conserve the utilisation of semi-essential 
amino acids, including  arginine66. Although creatine biosynthesis in mycoplasmas is still elusive and not fully 
described, these findings could be connected to arginine metabolism, as described above.
In relation to nucleotide Metabolism, levels of Uridine were higher in the biofilm than planktonic state after 
for both M. fermentans and M. pneumoniae (Figs. 2 and 6) Uridine nucleic acid derivatives could be used as a 
precursor of polysaccharides, such as exopolysaccharide (EPS), which is important in the maintenance of bio-
film  structure25. In Mycoplasma pneumoniae, Uridine is involved in the Leloir pathway that comprises a step in 
galactose  phosphorylation67. Furthermore, EPS production requires both free galactose and the Leloir pathway 
in order to form a  biofilm67.
Conclusion
This work is the first study to quantify a set of key metabolites, including glycolysis compounds, amino acids, and 
nucleotides, in the growth of human mycoplasmas. The results obtained suggested that metabolic pathways in 
human mycoplasmas, such as M. fermentans and M. pneumoniae were regulated by multiple enzymatic reactions 
in order to fulfil key metabolic activities. Therefore, protein abundance in the metabolic network could provide 
a qualitative picture of M. fermentans and M. pneumoniae metabolic pathway activity in both biofilm and plank-
tonic cells under laboratory growth conditions. There are examples of how metabolomic differences have been 
observed in in planktonic and biofilm cells of Mycoplasma genitalium46, Staphylococcus aureus44,45, Gardnerella 
vaginalis47 and Rhizobium alamii48. Whilst these studies all discuss the difference in metabolomic profiles in the 
species discussed between planktonic and biofilm growth states, none look at the rate of metabolism. As there 
is a range of growth states throughout a biofilm from the apical to the basolateral surface measuring the rate of 
growth is widely viewed as not possible. As a result, studies often analyse the production of materials, compounds 
metabolic markers from the biofilm as a whole and not the rate of metabolism as this is not currently possible. 
Hence the data presented here is the first use of DOSY-NMR to examine the metabolism of these mycoplasmas in 
their planktonic and biofilm growth states, as a whole and not on a rate wise basis. The clarification of metabolic 
pathway activity in both biofilm and planktonic cells enables us to gain a better understanding of vital and non-
essential metabolites involved in the formation and establishment of human mycoplasma biofilms.
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